Sherbrooke Park Advisers’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,527	Closed	-$65.6K	–	484
2023 Q3	$65.6K	Buy	+17,527	New	+$65.6K	0.02%	478